These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9053285)

  • 21. Angiogenesis--cytokines as part of a network.
    Sachs L
    EXS; 1992; 61():20-2. PubMed ID: 1377531
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphangiogenesis in malignant tumours: Does it occur?
    Clarijs R; Ruiter DJ; de Waal RM
    J Pathol; 2001 Feb; 193(2):143-6. PubMed ID: 11180158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis.
    Rosen EM; Zitnik RJ; Elias JA; Bhargava MM; Wines J; Goldberg ID
    EXS; 1993; 65():301-10. PubMed ID: 7678533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors.
    Neufeld G; Kessler O; Vadasz Z; Gluzman-Poltorak Z
    Surg Oncol Clin N Am; 2001 Apr; 10(2):339-56, ix. PubMed ID: 11382591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.
    Wang R; Zhao N; Li S; Fang JH; Chen MX; Yang J; Jia WH; Yuan Y; Zhuang SM
    Hepatology; 2013 Aug; 58(2):642-53. PubMed ID: 23468064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumoral vascularity as a prognostic factor in cancer.
    Weidner N; Folkman J
    Important Adv Oncol; 1996; ():167-90. PubMed ID: 8791135
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumour micrometastases: the influence of angiogenesis.
    McDonnell CO; Hill AD; McNamara DA; Walsh TN; Bouchier-Hayes DJ
    Eur J Surg Oncol; 2000 Mar; 26(2):105-15. PubMed ID: 10744927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factors: their potential as targets for an individualized therapeutic approach to cancer.
    Mees C; Nemunaitis J; Senzer N
    Cancer Gene Ther; 2009 Feb; 16(2):103-12. PubMed ID: 18846113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumorangiogenesis: a network of cytokines.
    Hotfilder M; Nowak-Göttl U; Wolff JE
    Klin Padiatr; 1997; 209(4):265-70. PubMed ID: 9293460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenic molecules and cancer metastasis.
    Kumar R; Fidler IJ
    In Vivo; 1998; 12(1):27-34. PubMed ID: 9575423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.
    Stetler-Stevenson WG
    Surg Oncol Clin N Am; 2001 Apr; 10(2):383-92, x. PubMed ID: 11382593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular determinants of angiogenesis in cancer metastasis.
    Fidler IJ; Kumar R; Bielenberg DR; Ellis LM
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S58-66. PubMed ID: 9619272
    [No Abstract]   [Full Text] [Related]  

  • 33. [A review of factors influencing the development of metastases].
    Skalková D
    Cesk Fysiol; 1986; 35(2):146-59. PubMed ID: 2424625
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.
    Vlodavsky I; Friedmann Y
    J Clin Invest; 2001 Aug; 108(3):341-7. PubMed ID: 11489924
    [No Abstract]   [Full Text] [Related]  

  • 35. [Similarities between angiogenesis and neoplasm invasiveness ].
    Stéhelin D
    C R Seances Soc Biol Fil; 1998; 192(2):217-22. PubMed ID: 9759364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic factors required in cancer invasion and metastasis.
    Abecassis J; Million R; Muller D; Eber M; Methlin G
    Prog Clin Biol Res; 1990; 348():23-33. PubMed ID: 1696736
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotactic factors, passive invasion and metastasis of cancer cells.
    Opdenakker G; Van Damme J
    Immunol Today; 1992 Nov; 13(11):463-4. PubMed ID: 1298279
    [No Abstract]   [Full Text] [Related]  

  • 38. The sweet and sour of cancer: glycans as novel therapeutic targets.
    Fuster MM; Esko JD
    Nat Rev Cancer; 2005 Jul; 5(7):526-42. PubMed ID: 16069816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New functions of stromal proteases and their inhibitors in tumor progression.
    Noel A; Albert V; Bajou K; Bisson C; Devy L; Frankenne F; Maquoi E; Masson V; Sounni NE; Foidart JM
    Surg Oncol Clin N Am; 2001 Apr; 10(2):417-32, x-xi. PubMed ID: 11382595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis.
    Samani AA; Brodt P
    Surg Oncol Clin N Am; 2001 Apr; 10(2):289-312, viii. PubMed ID: 11382588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.